| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.3 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.075 | 0.3 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.3 |